FDA Approves Roflumilast Foam for Scalp, Body Psoriasis ...Middle East

Medscape - News
FDA Approves Roflumilast Foam for Scalp, Body Psoriasis
The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and children aged 9 years and older. Medscape Medical News

Hence then, the article about fda approves roflumilast foam for scalp body psoriasis was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Roflumilast Foam for Scalp, Body Psoriasis )

Apple Storegoogle play

Last updated :

Also on site :